-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shijiazhuang Sihua Pharmaceutical Group Makes a Spectacular Appearance at the 2025 CPHI Frankfurt World Pharmaceutical Ingredients Exhibition
Category:
发布时间：2025-10-29
【概要描述】
On October 28 local time, the three-day CPHI Frankfurt 2025—the world’s largest specialized pharmaceutical industry exhibition—kicked off with great fanfare in Frankfurt, Germany. Shijiazhuang Sihua Pharmaceutical Group made a striking appearance at the show, showcasing its bulk and specialty APIs as well as finished dosage forms, actively expanding into the European market and continuously projecting a new image and demonstrating fresh achievements in corporate development.
On October 28, local time, the three-day CPHI Frankfurt—world’s largest specialized trade show for the pharmaceutical industry—kicked off with great fanfare in Frankfurt, Germany. Shijiazhuang Sihua Pharmaceutical Group made a striking appearance at the event, showcasing its bulk and specialty APIs as well as finished dosage forms, actively expanding into the European market and continuously projecting a new image and demonstrating fresh achievements in corporate development.
According to reports, since its inaugural edition in 1990, the World Pharmaceutical Raw Materials Exhibition has grown into a globally influential industry event, serving as a critical bellwether for the development of the pharmaceutical raw materials and intermediates sector. Each year, suppliers, manufacturers, distributors, and industry professionals from around the world converge at the exhibition to showcase the latest advancements, gain insights into emerging trends, and engage in forward-looking discussions. Today, the event has become an essential platform and gateway for Chinese pharmaceutical raw materials exporters to connect with global pharmaceutical companies and penetrate international markets.
“Accelerating the development of the European market is a key priority for the Group’s international API business, as this region is home to a large number of strategic partners. Through trade shows, we can not only engage in face-to-face communication and exchanges with our customers but also establish new partnerships and gain a deeper understanding of the demand and trends for APIs and finished dosage forms in both the European and global markets,” said the Group’s head of foreign trade.
At the exhibition, the Group’s spacious, bright, and open booth design drew considerable attention from both industry professionals and international business visitors. Its flagship specialty APIs and finished dosage forms were particularly well-received by European customers; in particular, its caffeine API has earned widespread recognition in global markets thanks to its high purity and full traceability, with annual sales continuing to grow. As one of the world’s leading caffeine suppliers, the Group has steadily optimized its manufacturing processes in recent years, achieving end-to-end green management across the entire value chain. In 2024, it obtained international carbon-footprint certification, and in 2025, it secured EU CEP certification. Its products are now exported to more than 60 countries and regions, significantly enhancing its competitive edge and brand influence in international markets.
Since the exhibition opened, the Group’s booth has been bustling with visitors, including long-term partners from global industry leaders as well as emerging brands. Through exchanges and negotiations, the Group has reached preliminary cooperation agreements with numerous clients.
“Leveraging the trade fair and engaging in in-depth interactions with international clients has laid a stronger foundation for both current market development and initiatives targeting 2026,” said the Group’s head of foreign trade. “Adhering to quality-first principles and delivering precision-driven services is the key to success in the global marketplace. Moving forward, we will accelerate the dual-track approach of innovation-driven growth and international cooperation, continuously elevating the Group’s global operations to a new level.”
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091